EAM
RPTP

EverPoint Asset Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

EverPoint Asset Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-325,000
Closed -$3.12M – 648
2014
Q3 		$3.12M Buy
+325,000
New +$3.32M 0.07% 310

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

EverPoint Asset Management's RPTP Position: Q4 2014 in Review

EverPoint Asset Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2014, closing a stake of 325,000 shares — an estimated $3.12M sold.

EverPoint Asset Management first reported a position in RPTP in Q3 2014 and held it in 1 quarter. The position peaked at $3.12M in Q3 2014. 81 funds tracked by Wall St. Rank hold RPTP as of Q4 2014.

  • EverPoint Asset Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • EverPoint Asset Management sold 325,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2014, an estimated $3.12M.
  • EverPoint Asset Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2014 and held it in 1 quarter.
  • EverPoint Asset Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $3.12M in Q3 2014.
  • 81 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2014.

Based on EverPoint Asset Management's 13F filing for Q4 2014, filed 17 Feb 2015.